Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Orsini - Rare Disease Pharmacy SolutionsOrsini - Rare Disease Pharmacy Solutions
VS
Astellas PharmaAstellas Pharma
Orsini - Rare Disease Pharmacy Solutions

Orsini - Rare Disease Pharmacy Solutions

1111 Nicholas Blvd., Elk Grove Village, 60007, US

Last Update: 04/04/2026

View Profile
Between 700 and 749
http://www.orsini.com
716/1000Moderate

Providing patients with comprehensive and compassionate care since 1987, Orsini is the leading, independent specialty pharmacy focused on rare diseases, gene therapies, and complex conditions. Orsini’s high-touch care model centers around compassionate, therapy-specific...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:348
Subsidiaries:0
12-month incidents
0
Known data breaches
1
Attack type number
1
Astellas Pharma

Astellas Pharma

N/A

Last Update: 07/09/2026

View Profile
Between 800 and 849
http://www.astellas.com/
800/1000Good

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and develo...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12,597
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Orsini - Rare Disease Pharmacy Solutions

Orsini - Rare Disease Pharmacy Solutions

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Astellas Pharma

Astellas Pharma

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Orsini - Rare Disease Pharmacy Solutions in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Astellas Pharma in 2026.

Incidents

Incident History - Orsini - Rare Disease Pharmacy Solutions (X = Date, Y = Severity)

Orsini - Rare Disease Pharmacy Solutions cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Astellas Pharma (X = Date, Y = Severity)

Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Orsini - Rare Disease Pharmacy Solutions

Orsini - Rare Disease Pharmacy Solutions

Incidents
🔒 Incident : Breach
ORS357072525
Astellas Pharma

Astellas Pharma

Incidents
No explicit notable incidents reported.

FAQ

Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one has the best AI Cybersecurity Score ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one has experienced more cyber incidents in the past ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one has experienced more cyber incidents this year ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one has experienced at least one ransomware attack ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one has experienced at least one data breach ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one has experienced at least one targeted cyberattack ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one has experienced at least one vulnerability ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one holds the most compliance certifications ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one holds the fewest compliance certifications ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one has the most subsidiaries ?
Between Orsini - Rare Disease Pharmacy Solutions company and Astellas Pharma company, which one has the largest number of employees ?
Between Orsini - Rare Disease Pharmacy Solutions and Astellas Pharma, which company holds both SOC 2 Type 1 certifications ?
Between Orsini - Rare Disease Pharmacy Solutions and Astellas Pharma, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Orsini - Rare Disease Pharmacy Solutions or Astellas Pharma ?
Which company is PCI DSS compliant - Orsini - Rare Disease Pharmacy Solutions or Astellas Pharma ?
Between Orsini - Rare Disease Pharmacy Solutions and Astellas Pharma, which company complies with HIPAA regulations for healthcare data ?
Between Orsini - Rare Disease Pharmacy Solutions and Astellas Pharma, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-95828
SUMMARY

A vulnerability was determined in Mstfakts College-Management-System. This affects the function session_start of the file Front-end/server.php of the component Authentication. Executing a manipulation can lead to session fixiation. It is possible to launch the attack remotely. The exploit has been publicly disclosed and may be utilized. This product takes the approach of rolling releases to provide continious delivery. Therefore, version details for affected and updated releases are not available. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 4.3)
CVSS2
Base Score: 5.0
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:N/A:N
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-95820
SUMMARY

A vulnerability was found in anirbandutta9 College-Notes-Gallery up to 8c1cf3d98f30982d069c88ca172612c001eb39f6. Affected by this issue is some unknown functionality of the file /dashboard/userprofile.php?section=admin1. Performing a manipulation of the argument image results in unrestricted upload. It is possible to initiate the attack remotely. The exploit has been made public and could be used. This product is using a rolling release to provide continious delivery. Therefore, no version details for affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-61685
SUMMARY

ReactPress is a publishing system for React developers. Prior to version 3.7.0, ReactPress API list endpoints build TypeORM `QueryBuilder` conditions using unsanitized HTTP query parameter names as SQL column identifiers (e.g. `` `article.${key}` ``). TypeORM parameterizes values but not column names, allowing unauthenticated attackers to inject SQL through crafted query string keys. Version 3.7.0 contains a patch. As a workaround, allowlist allowed filter column names before interpolating into SQL.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-57576
SUMMARY

plone.app.dexterity is a content-type system for the Plone content management system, and plone.app.contenttypes provides Plone’s Dexterity-based content types. Plone.app.dexterity versions through 3.2.2, 4.0.0 through 4.1.2, and 5.0.0, and plone.app.contenttypes versions through 3.0.11, 4.0.0 through 4.0.9, and 5.0.0 are vulnerable to denial of service because an authenticated user can create content with excessively long titles, descriptions, or uploaded-file names, causing Plone to become unresponsive and potentially making the resulting content difficult to edit or delete. The vulnerability is patched in plone.app.dexterity versions 3.2.3, 4.1.3, and 5.0.1, and in plone.app.contenttypes versions 3.0.12, 4.0.10, and 5.0.1.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-18176
SUMMARY

IBM Financial Transaction Manager (FTM) for RedHat OpenShift could allow a remote attacker to obtain sensitive information due to cleartext transmission of sensitive information.

PUBLISHED
Date2026-09-22
UPDATED
Date2026-09-22
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: LOW
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
IMPACT SCORE
4
EXPLOITABILITY
2.8